You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Johnson and Johnson
Baxter
Mallinckrodt
Express Scripts

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PRX-08066

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for PRX-08066?

PRX-08066 is an investigational drug.

There have been 21 clinical trials for PRX-08066. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2005.

The most common disease conditions in clinical trials are Disease, Alzheimer Disease, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Epix Pharmaceuticals, Inc., Protalix, and Presbyopia Therapies, LLC.

Recent Clinical Trials for PRX-08066
TitleSponsorPhase
Prodrug PRX-P4-003 Microdose StudyPraxis Bioresearch, LLCEarly Phase 1
INDUCTION CHEMO-IMMUNOTHERAPY FOLLOWED BY CONSOLIDATION WITH REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANT IN ADVANCED STAGE MATURE NON-ANAPLASTIC T-CELL OR NK LYMPHOMA/LEUKEMIA IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTSUniversity of Alabama at BirminghamEarly Phase 1
INDUCTION CHEMO-IMMUNOTHERAPY FOLLOWED BY CONSOLIDATION WITH REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANT IN ADVANCED STAGE MATURE NON-ANAPLASTIC T-CELL OR NK LYMPHOMA/LEUKEMIA IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTSNew York Medical CollegeEarly Phase 1

See all PRX-08066 clinical trials

Clinical Trial Summary for PRX-08066

Top disease conditions for PRX-08066
Top clinical trial sponsors for PRX-08066

See all PRX-08066 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Johnson and Johnson
Baxter
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.